Cart (0 Items)
Your cart is currently empty.
View ProductsSize | 100ug |
---|---|
Brand | Arovia |
Product type | Recombinant Proteins |
Product name | Recombinant Human VPS8 Protein, N-His |
---|---|
Origin species | Human |
Expression system | Prokaryotic expression |
Molecular weight | 19.79 kDa |
Buffer | Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol. |
Form | Liquid |
Delivery condition | Dry Ice |
Delivery lead time in business days | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | 4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection) |
Brand | Arovia |
Host species | Escherichia coli (E.coli) |
Fragment Type | Val819-Glu966 |
Aliases /Synonyms | VPS8, KIAA0804, Vacuolar protein sorting-associated protein 8 homolog |
Reference | ARO-P10728 |
Note | For research use only. |
Recombinant Human VPS8 Protein, also known as Vacuolar Protein Sorting 8 Homolog (VPS8), is a protein that plays a crucial role in intracellular protein trafficking and sorting. It is a member of the VPS8 family, which is involved in the formation and maturation of endosomes, lysosomes, and autophagosomes. Recombinant VPS8 Protein is produced through genetic engineering techniques, making it a highly pure and specific protein with a wide range of applications in various fields of research and medicine.
Recombinant Human VPS8 Protein is a 102 kDa protein consisting of 925 amino acids. It contains a conserved VPS8 domain, which is responsible for its function in intracellular trafficking. The protein also has several other domains, including a coiled-coil domain, a WD40 repeat domain, and a C2 domain. These domains are essential for protein-protein interactions and membrane binding, allowing VPS8 to perform its cellular functions.
Recombinant Human VPS8 Protein is involved in the process of endosomal sorting and trafficking. It functions as a subunit of the Class C VPS complex, which is responsible for the fusion of endosomes with lysosomes and the formation of multivesicular bodies. VPS8 interacts with other subunits of the VPS complex, such as VPS11 and VPS18, to regulate the formation and maturation of endosomes and lysosomes. It also plays a role in autophagosome formation, a process that involves the degradation of cellular components through the lysosomal pathway.
Recombinant Human VPS8 Protein has a wide range of applications in both research and medicine. Its role in intracellular trafficking makes it a valuable tool for studying the mechanisms of endosome and lysosome formation. It can also be used to investigate the molecular basis of diseases related to defects in these processes, such as lysosomal storage disorders and neurodegenerative diseases.
Furthermore, Recombinant Human VPS8 Protein has potential therapeutic applications. It has been identified as a potential target for cancer therapy, as it is involved in the regulation of cell growth and proliferation. Studies have shown that inhibiting VPS8 activity can lead to the death of cancer cells, making it a promising target for the development of anti-cancer drugs.
In addition, Recombinant Human VPS8 Protein has been shown to play a role in the immune response. It is a key player in the antigen processing and presentation pathway, where it helps to deliver antigens to MHC class II molecules for presentation to T cells. This makes it a potential target for the development of vaccines and immunotherapies.
Recombinant Human VPS8 Protein is a crucial protein involved in intracellular trafficking and sorting. Its structure and activity have been extensively studied, and it has been identified as a potential therapeutic target for various diseases. Its wide range of applications in research and medicine make it a valuable tool for understanding cellular processes and developing new treatments. With further research, Recombinant Human VPS8 Protein has the potential to make significant contributions to the fields of biology, medicine, and biotechnology.
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.